Fierce Health Payers January 28, 2020
Robert King

Editor’s note: A previous version of this story incorrectly identified who receives the drug discounts.

The federal government isn’t doing a good job of determining whether a drug company has to provide both 340B discounts and rebates for Medicaid, a federal watchdog said.

The Government Accountability Office (GAO) said in a report Tuesday (PDF) that the Centers for Medicare & Medicaid Services (CMS) only provides limited oversight of state efforts to quash duplicate discounts. Audits from the Health Resources and Services Administration (HRSA) are also lacking, the report found.

A safety net hospital can qualify to get a 25% to 50% discount for drug products under 340B, but those facilities are not eligible for drug rebates from Medicaid. A...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: GAO, Govt Agencies, Insurance, Market Research, Medicaid, Pharma, States, Trends
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
DOJ Accuses Walgreens of Filling Millions of Illegitimate Prescriptions
DOJ sues Walgreens for allegedly filling millions of illegal prescriptions, including opioids

Share This Article